PharmaCyte Biotech, Inc.

Historical 13F Holders

Symbol
PMCB
CUSIP
71715X203
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 71715X203 since 12/18/2024, largest first.

Filer % of Class Filed
Ayrton Capital LLC 13G/A
9.9% 2/13/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Intracoastal Capital LLC 13G/A
4.99% 2/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 29 763 k $586 k
2026 Q1 33 968 k $643 k
2025 Q4 29 984 k $712 k
2025 Q3 24 433 k $420 k
2025 Q2 24 577 k $632 k
2025 Q1 27 568 k $710 k
2024 Q4 24 601 k $934 k
2024 Q3 28 826 k $1.58 M
2024 Q2 31 1.03 M $2.02 M
2024 Q1 35 978 k $2.32 M
2023 Q4 37 1.09 M $2.35 M
2023 Q3 34 1.14 M $2.40 M
2023 Q2 32 1.21 M $3.47 M
2023 Q1 35 3.53 M $10.2 M
2022 Q4 38 3.45 M $10.1 M
2022 Q3 36 4.98 M $12.0 M
2022 Q2 38 3.92 M $8.79 M
2022 Q1 30 3.84 M $8.83 M
2021 Q4 33 3.47 M $8.68 M
2021 Q3 25 1.40 M $4.42 M